Impax Hit With Investor Class Action After FDA Criticism
Impax Laboratories Inc. was hit with a putative class action in California federal court Wednesday, accusing the drugmaker of misleading investors about quality control problems that led to a so-called Form...To view the full article, register now.
Already a subscriber? Click here to view full article